Suppr超能文献

印度医学生对 COVID-19 疫苗的犹豫。

COVID-19 vaccine hesitancy among medical students in India.

机构信息

All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, 342005, Rajasthan, India.

Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences (AIIMS), Basni, Jodhpur, Rajasthan342005, India.

出版信息

Epidemiol Infect. 2021 May 20;149:e132. doi: 10.1017/S0950268821001205.

Abstract

The coronavirus disease 2019 (COVID-19) vaccine was launched in India on 16 January 2021, prioritising health care workers which included medical students. We aimed to assess vaccine hesitancy and factors related to it among medical students in India. An online questionnaire was filled by 1068 medical students across 22 states and union territories of India from 2 February to 7 March 2021. Vaccine hesitancy was found among 10.6%. Concern regarding vaccine safety and efficacy, lack of awareness regarding their eligibility for vaccination and lack of trust in government agencies predicted COVID-19 vaccine hesitancy among medical students. On the other hand, the presence of risk perception regarding themselves being affected with COVID-19 reduced vaccine hesitancy as well as hesitancy in participating in COVID-19 vaccine trials. Vaccine-hesitant students were more likely to derive information from social media and less likely from teachers at their medical colleges. Choosing between the two available vaccines (Covishield and Covaxin) was considered important by medical students both for themselves and for their future patients. Covishield was preferred to Covaxin by students. Majority of those willing to take the COVID-19 vaccine felt that it was important for them to resume their clinical posting, face-to-face classes and get their personal life back on track. Around three-fourths medical students viewed that COVID-19 vaccine should be made mandatory for both health care workers and international travellers. Prior adult vaccination did not have an effect on COVID-19 vaccine hesitancy. Targeted awareness campaigns, regulatory oversight of vaccine trials and public release of safety and efficacy data and trust building activities could further reduce COVID-19 vaccine hesitancy among medical students.

摘要

2019 年冠状病毒病(COVID-19)疫苗于 2021 年 1 月 16 日在印度推出,优先考虑包括医学生在内的医疗保健工作者。我们旨在评估印度医学生对疫苗的犹豫态度及其相关因素。2021 年 2 月 2 日至 3 月 7 日,来自印度 22 个邦和联邦属地的 1068 名医学生在线填写了问卷。发现有 10.6%的人对疫苗犹豫不决。对疫苗安全性和有效性的关注、对自己接种资格的认识不足以及对政府机构的信任缺乏,都预示着医学生对 COVID-19 疫苗的犹豫。另一方面,对自己感染 COVID-19 的风险感知的存在,既降低了对 COVID-19 疫苗的犹豫,也降低了对参与 COVID-19 疫苗试验的犹豫。疫苗犹豫不决的学生更有可能从社交媒体获取信息,而不太可能从医学院的教师那里获取信息。医学生认为,在两种可用的疫苗(Covishield 和 Covaxin)之间进行选择,无论是对他们自己还是对他们未来的患者来说都很重要。学生们更喜欢 Covishield 而不是 Covaxin。大多数愿意接种 COVID-19 疫苗的人认为,对他们来说,恢复临床实习、面对面上课和恢复个人生活是很重要的。大约四分之三的医学生认为 COVID-19 疫苗应该对医护人员和国际旅行者强制接种。成人以前接种疫苗对 COVID-19 疫苗犹豫没有影响。有针对性的宣传活动、疫苗试验的监管监督、安全性和有效性数据的公开发布以及建立信任的活动,可以进一步降低医学生对 COVID-19 疫苗的犹豫。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验